-
公开(公告)号:US20240190839A1
公开(公告)日:2024-06-13
申请号:US18340978
申请日:2023-06-26
Applicant: Insilico Medicine IP Limited
Inventor: Jianping Wu , Luoheng Qin , Jinxin Liu
IPC: C07D401/14 , A61P35/00
CPC classification number: C07D401/14 , A61P35/00
Abstract: The disclosure provides for small molecules inhibitory compounds of ubiquitin specific protease 1 (USP1) and compositions comprising the same. The disclosure further provides methods for targeting ubiquitin specific protease 1 (USP1) and methods of treating diseases or disorders related to USP1, such as cancer.
-
公开(公告)号:US12103915B2
公开(公告)日:2024-10-01
申请号:US18529689
申请日:2023-12-05
Applicant: Insilico Medicine IP Limited
Inventor: Xiao Ding , Jinxin Liu , Feng Ren , Jianfei Wan , Wei Zhu
IPC: C07D231/56 , A61P35/00 , C07D209/44 , C07D215/14 , C07D401/04 , C07D403/08 , C07D471/04 , C07D487/04
CPC classification number: C07D231/56 , A61P35/00 , C07D209/44 , C07D215/14 , C07D401/04 , C07D403/08 , C07D471/04 , C07D487/04
Abstract: The disclosure provides for compounds and methods for modulating or inhibiting TEAD. Further provided herein are pharmaceutical compositions comprising the TEAD inhibitors and methods of treatment using the TEAD inhibitors or the pharmaceutical compositions.
-
公开(公告)号:US11739077B2
公开(公告)日:2023-08-29
申请号:US18106339
申请日:2023-02-06
Applicant: Insilico Medicine IP Limited
Inventor: Jianping Wu , Luoheng Qin , Jinxin Liu
IPC: C07D401/14 , A61P35/00
CPC classification number: C07D401/14 , A61P35/00
Abstract: The disclosure provides for small molecules inhibitory compounds of ubiquitin specific protease 1 (USP1) and compositions comprising the same. The disclosure further provides methods for targeting ubiquitin specific protease 1 (USP1) and methods of treating diseases or disorders related to USP1, such as cancer.
-
公开(公告)号:US20230183210A1
公开(公告)日:2023-06-15
申请号:US18106339
申请日:2023-02-06
Applicant: Insilico Medicine IP Limited
Inventor: Jianping Wu , Luoheng Qin , Jinxin Liu
IPC: C07D401/14 , A61P35/00
CPC classification number: C07D401/14 , A61P35/00
Abstract: The disclosure provides for small molecules inhibitory compounds of ubiquitin specific protease 1 (USP1) and compositions comprising the same. The disclosure further provides methods for targeting ubiquitin specific protease 1 (USP1) and methods of treating diseases or disorders related to USP1, such as cancer.
-
-
-